Advent Life Sciences
VC · London · United Kingdom
Stages
Investment region
Industries
Profile
Advent Life Sciences is a venture capital firm based in London, founded in 2006. The firm specializes in life sciences investments with a focus on building innovative businesses in the UK, Europe, and the USA. The team comprises experienced entrepreneurs and investors who have a strong track record in turning breakthrough science into approved medicines and medical products. This hands-on team supports portfolio companies closely and aligns with management teams to realize their visions. Advent Life Sciences invests in early and mid-stage companies, with particular interest in new drug discovery, med tech, enabling technologies, and vaccines. The firm focuses on seed and Series A stages with a geographical interest in trans-Atlantic opportunities. Advent's portfolio boasts companies that have brought 15 innovative medicines and products to market since its inception. Notable investments include Pheno Therapeutics - multiple sclerosis therapies, F2G - antifungal treatments, Amphista Therapeutics - cancer treatments, and other leading edge life sciences companies. These significant investments reflect the firm's strength in identifying and supporting high-potential ventures in the life sciences sector.
Contacts (2)
| Name | Title | Phone | ||
|---|---|---|---|---|
| General Partner | — | — | — | |
| General Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.